Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. A. Zelberg"'
Autor:
M. A. Zelberg, N. Yu. Mironov, Kh. M. Dzaurova, Yu. A. Yuricheva, E. B. Maykov, P. S. Novikov, D. A. Gagloeva, M. A. Krimukova, S. F. Sokolov, S. P. Golitsyn
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 86-95 (2024)
Objective. Evaluate efficacy and safety of cavutilide (Refralon) for pharmacological cardioversion in patients with recurrent atrial fibrillation and flutter (AF/AFL), in 90days blanking period of catheter ablation.Materials and methods. included 56
Externí odkaz:
https://doaj.org/article/22ac86e42166436abe584631dc932ef7
Autor:
D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 4 (2023)
Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibrillation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxy
Externí odkaz:
https://doaj.org/article/9421170c3fc74df083e12f23e2bc4e63
Autor:
S. F. Sokolov, N. Yu. Mironov, Sergey P. Golitsyn, N. A. Mironova, P Novikov, Yu. A. Yurichev, M. A. Zelberg, E. B. Maykov
Publikováno v:
Journal of Arrhythmology. 28:55-62
We present two cases of successful pharmacological cardioversion using antiarrhythmic drug refralon in patients with persistent atrial fibrillation after pulmonary vein cryoablation and ineffective electrical cardioversion. These clinical cases repre